It is currently Sun Feb 01, 2015 5:49 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Primary & secondary progressive MS drug progress update

MedDay, a biotechnology company that develops new drugs for nervous system disorders, announced an update on the progress of its development pipeline with its lead product MD1003 for the treatment of primary and secondary progressive multiple sclerosis (MS). The first study is expected to be complete in early 2015, while the second should be complete in late 2015....... Read More - http://www.ms-uk.org/emergingtherapies
Read more : Primary & secondary progressive MS drug progress update | Views : 310 | Replies : 0


Results from phase1b APD334 for autoimmune diseases released

Arena Pharmaceuticals, Inc. released the first results from its phase 1b trial that for the evaluation of an oral drug candidate called APD334 for the treatment of autoimmune diseases, such as multiple sclerosis (MS). The multiple ascending dose clinical trial demonstrated encouraging findings about the drug, which is designed to target the sphingosine 1-phosphate subtype 1 (S1P1) receptor............ Read More - http://www.ms-uk.org/emergingtherapies
Read more : Results from phase1b APD334 for autoimmune diseases released | Views : 281 | Replies : 0


Update on progress of progressive MS drug MD1003

MedDay provides update on progress of progressive MS drug MD1003

MedDay has provided an update on the progress of its lead product MD1003 for the treatment of primary and secondary progressive multiple sclerosis (MS), which is expected to complete its first pivotal study in Q1 2015. A second pivotal study is on track for completion by the end of 2015.... Read More - http://www.ms-uk.org/emergingtherapies
Read more : Update on progress of progressive MS drug MD1003 | Views : 405 | Replies : 3




New MS drug shows some promise in repairing eye nerve damage

Possible new MS drug shows some promise in repairing eye nerve damage

Biogen Idec Inc’s experimental drug for multiple sclerosis showed signs that it could help repair nerve damage in patients’ eyes, a tentatively positive step for a drug aimed at reversing progression of the disease.

In a mid-stage trial of 82 patients, Biogen’s drug showed a 34 percent improvement in those who completed the study. The result fell a hair below the threshold for ...
Read more : New MS drug shows some promise in repairing eye nerve damage | Views : 318 | Replies : 0


Neuropathy Treatment Group--I.D.--Wes Jones -President

Has anybody tried these pills for neuropathy treatment? Has it been beneficial or not ?
It seems as these pills are different vitamin B forms `ramped up` and into one pill.
Does anybody think that this might be harmful for MS patients to take due to the fact that it might be a immune enhancer? :roll:
Read more : Neuropathy Treatment Group--I.D.--Wes Jones -President | Views : 248 | Replies : 0


Plegridy

My neuro is wanting me to start Plegridy soon. Anyone have experience with that? So far I've only tried Tecfidera but had to stop due to side effects.
Read more : Plegridy | Views : 339 | Replies : 0


Seroquel, to remyelinate?

http://mssociety.ca/en/help/msupdates/msupdate_20131118.htm

The Drug, Seroquel, is being tested for remyelination, in mice with EAE.
I am taking this drug, and hating it. A web search for Seroquel multiple sclerosis turned this up.
Silver lining, maybe?
Read more : Seroquel, to remyelinate? | Views : 369 | Replies : 2




IMMUNE TRETMENT FOR MS SHOWS PROMISE

HI Friends please read for details
http://www.medicalnewstoday.com/articles/272326.php
regards
seeva
Read more : IMMUNE TRETMENT FOR MS SHOWS PROMISE | Views : 446 | Replies : 0


 

Login  •  Register


Statistics

Total posts 223365 • Total topics 23221 • Total members 14699


Contact us | Terms of Service